Member Info for sweepie3

With the DA loan paid back and the two recent placings it probably adds up to over £1m and yet they have just reinvested around £200k. If money is raised and just 20% of it is reinvested back into the business is this not a bit of day light robbery. Good thing is that you would have thought that ALL shareholders apart from directors and affiliates will be voting for more shares to be issued. Why should they be issued we see a decline in percentages anyway and the majority of the funds raised by a bucket shop at a huge discount and the majority going on salaries and expenses. Despite the investments doing well we have lambs in charge who are savaged by the corporate wolves to steal our holdings in DA or due to our useless directors are incapable of getting an exit away. Why would shareholders vote for more of the same??

The fact that they didn't break down how much is going to buy Wyld warrants makes me expect its a tiny amount of the overall raise, the majority of the raise will as somebody said will be spent on salaries and no doubt an increase in expenses, has a fleet of cars for the directors been ordered. I wouldn't put anything past this lot. Come the AGM both of the directors will be gone, pity we don't have a ruling that they have to repay all the ill deserved wages if they muck up and fail time and time again

Penny Stock

@mulzynski

·

8h

#tern GOOD STRATEGY

Tern sold Wyld shares for 13sek and buying back for 2.5sek

Tern will get more shares in

@WyldNetworks

before EXIT

Wyld signed many new contracts for mln of $$$ and takeover by #SpaceX can happen anytime!

Time to buy more Tern plc with 30% discounts 2.4p

This placing is being gobbled up at a rate of knots

Release good news to get away yet another cheap placing, they are so bloody obvious, one positive that they sold Wyld shares at around 11sek and now buying them all back at around 2.5sek but hands up who is royally fed up with this lot

Comprehensive Surgical VR Training is Powering Competence and Growth in Endovascular and Robotics

$

Home

$

Company Updates

$

Comprehensive Surgical VR Training is Powering Competence and Growth in Endovascular and Robotics

Virtual Reality training has emerged as a pivotal tool in the evolution of surgical training.

Published April 9, 2024

Author: Dr. Caitlin Houghton, Assistant Professor of Surgery at Keck Medicine of USC

Immersive VR offers streamlined training solutions that remove dependence on more traditional training methods, reducing the reliance on expensive cadaver and wet labs in favor of more agile and adaptive VR offerings.

Surgical robotics and training expert Dr. Caitlin Houghton (Keck Medicine of USC) identifies some of the key advantages of VR simulation utilization, including improved confidence, competence, and increased access to real-time feedback and assessment. Getting students and trainers onboard to adopt and deliver new techniques and technologies is easier than ever, with the ability to deploy VR simulations at scale and at any location. This allows for risk-free practice outside the confines of the classroom or operating room.

No longer are surgical students limited to education by one expert, specialist, or surgeon. VR is the vehicle for endless interactions with surgeons across specialties.

1790006013 1

“We have to think about sustainability and growth, instead of just adoption…you need a platform that’s going to continually change with you, continually let new learners be brought into the system… whether they’re nursing staff or new surgeons. Adoption seems finite. You might not invest in adoption, but you would invest in growth and sustainability.”

Dr. Caitlin Houghton, Assistant Professor of Surgery at Keck Medicine of USC

Emerging tech companies should prioritize investing in VR training modalities to accelerate the adoption of these platforms to grow surgical skills at an accelerated pace. VR platforms provide a common ground for collaboration across medical specialties, time zones, trainers, and students alike, all with the goal of improving patient care and outcomes worldwide.

Wyld Networks

@WyldNetworks

·

2h

We are excited to share our latest Wyld Connect and Wyld Fusion updates with the #LoRaWAN ecosystem in the marketplace at #LoRaWANLive Munich. We look forward to seeing you this June.

Register NOW to join us:

https://bit.ly/LoRaWANLive-Munich

Always a danger when they release good news, they usually only release bad news and ignore the good stuff

This sort of web page needed for various events like an IPO, are we heading down that road?

https://talkingmedicines.com/compliance-hub/

LSI USA 2024 | The Adoption of Immersive VR to Drive Digital Surgery

$

Home

$

Events & Webinars

$

On Demand

$

LSI USA 2024 | The Adoption of Immersive VR to Drive Digital Surgery

ON DEMAND

LSI USA 2024 | The Adoption of Immersive VR to Drive Digital Surgery

Speaking at LSI USA, Richard Vincent shares how FundamentalVR is removing friction and shortening the learning curve for medical devices and procedures by developing immersive VR solutions that deliver Competency @ Scale.

“The key challenge with the move to digital surgery is really about the skills transfer… I’m talking about tenured surgeons, their teams, their nursing, their tech, who need to acquire new skills around the digital surgery space…And that’s where FundamentalVR comes in – we get into that space and virtualize it.”

Richard Vincent, CEO and Co-Founder of FundamentalVR

https://fundamentalsurgery.com/lsi-usa-2024-the-adoption-of-immersive-vr-to-drive-digital-surgery/

Blue day but no numbers will make any increase restrained but target was £3m, with them ahead of expectations, new target could well be alot higher, looks like TM are on fire, first RNS in a long time to get me looking forward to trading at 8am

According to the recent presentation companies like TM are valued at up to x50 revenues then this impressive growth might yet make TM into the jewel of Tern's portfolio, If they are that far ahead then Tern's stake could be worth around £115m if that valuation is spot on

Exciting times again maybe

Talking Medicines reports record revenue bookings and strategic partnerships in Q1 2024

Tern Plc (AIM:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things ("IoT") technology businesses, is pleased to note that Talking Medicines Limited ("Talking Medicines"), a company in which Tern currently holds 23.8% of the equity, has announced an update on its Q1 2024 performance, extracts of which are set out below.

Extracts from the Talking Medicines announcement:

"Talking Medicines, a pioneering leader in healthcare intelligence leveraging advanced data science and artificial intelligence, is pleased to announce a strong start to 2024, marked by record revenue bookings and significant advancements in its innovative platform, Talking Medicines Drug-GPT.

In the first quarter of 2024, Talking Medicines achieved significant success with its Talking Medicines Drug-GPT platform, which aims to revolutionise access to intelligence on pharmaceutical medicine brands and disease areas. This innovative technology has garnered substantial interest from leading global healthcare advertising agencies, who recognise its potential to transform strategies for pharmaceutical clients.

Among Talking Medicines' clients are some of the world's most prominent healthcare advertising agency networks, reaffirming the platform's efficacy in providing key insights derived from aggregated patient and healthcare professional conversations. By tapping into previously unseen data, Talking Medicines empowers its clients to drive better strategies and make informed decisions in relation to the pharmaceutical landscape.

Furthermore, Talking Medicines has forged strategic partnerships with both open and closed data communities, solidifying its commitment to expanding access to crucial insights. Notable among these partnerships is the collaboration with data aggregator Socialgist, which enables Talking Medicines to tap into millions of public conversational sites, enriching the Talking Medicines Drug-GPT platform with a wealth of diverse data sources.

Speaking on these achievements, Jo Halliday CEO expressed excitement about the company's trajectory and the transformative impact of Talking Medicines Drug-GPT on the healthcare industry: "We are thrilled by the broad response to Talking Medicines Drug-GPT and our strategic partnerships. This success underscores our dedication to empowering healthcare stakeholders with actionable insights derived from advanced data science and artificial intelligence."

Looking ahead, Talking Medicines remains committed to driving innovation and fostering collaborations that enhance healthcare decision-making through intelligence globally."

Https://talkingmedicines.com/2024/04/the-fusion-of-ai-and-strategy-a-look-through-drug-gpt/

Remember every time we get a tweet to say this has gone live, this is now producing data means its up to $5 a month income per sensor with little costs to generate that $5, should be in a position to move into Wyld very soon as CGT just been paid, fingers crossed its before the market catches on

The tool is intentionally designed to train surgeons in low- and middle-income countries, home to nine out of ten people with vision loss due to the difficulty of accessing eye care.

Published April 5, 2024

BOSTON, MA – April 5, 2024 – Orbis International and FundamentalVR today launched a new immersive virtual reality (VR) training solution intentionally designed for use in low- and middle-income countries, at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. The tool is built to support students and residents learning to perform surgery to treat cataracts – the world’s leading cause of blindness, despite being treatable with a short operation – ultimately growing the number of skilled care providers and improving outcomes for patients. The tool’s affordability, portability and scalability, combined with its targeted functionality, make it a key advancement in ophthalmic surgical education globally and will accelerate Orbis’s efforts to build strong and sustainable eye care systems around the world.

Orbis, a global nonprofit, teamed up with FundamentalVR, a technology company dedicated to developing VR surgical training solutions, to create this unique tool. It integrates VR, haptic feedback, cloud assessment data, and off-the-shelf hardware to create a solution for cataract surgical training in resource-limited settings. Immersive VR simulation integrated with haptics provides a highly realistic experience for eye-care professionals, who are able to practice each step repeatedly to cement their understanding of both basic and difficult techniques.

“We saw a real need that we could meet. Most existing simulation training tools are expensive, not easily transportable or sourced, and/or train doctors on a surgical method usually only practiced in high-resource areas. Thanks to our partnership with FundamentalVR, we were able to bring a new VR solution to life that makes cataract surgical training accessible no matter where you live.”

Dr. Hunter Cherwek, Orbis Vice President of Clinical Services and Technologies

The training tool enables independent learning through automated performance monitoring and feedback, a particular benefit to medical professionals without access to robust ophthalmic training opportunities. Residents can hone their skills in a realistic simulation, practicing first in a safe environment before entering the operating room, which is proven to yield better surgical outcomes. Users of the platform can supplement their learning with Cybersight, Orbis’s telemedicine and e-learning platform.

“Our partnership with Orbis International not only underscores our commitment to advancing the field of ophthalmology but also highlights the immense potential of VR in creating safer, more effective learning environments for healthcare professionals. Our goal is to elevate patient outcomes and redefine the standard of surgical proficiency on a global scale, advancing the qu

Wyld Networks, a lead provider of sensor-to-satellite connectivity solutions for IoT, is thrilled to announce its participation in Connected North 2024, a premier regional forum dedicated to advancing digital connectivity in the North of the UK. The event is scheduled to be held on April 22nd and 23rd, 2024, at Manchester Central.

Connected North 2024 aims to address the imperative need for enhanced connectivity in the Northern region of the UK, aligning with the government's commitment to making gigabit capable networks accessible for 85% of the country by the end of 2025. Beyond governmental targets, the focus is on enriching lives within local communities, fostering opportunities for regional businesses, and bolstering the global competitiveness of the region. This pivotal event will convene 200 expert speakers and 2,500 attendees from various sectors of the digital economy ecosystem, facilitating discussions on connectivity-driven social and economic growth.

The conference will explore key themes such as strategies for upgrading digital infrastructure, funding mechanisms, and the transformative potential of government policies. It will delve into tailored technology solutions and delivery strategies aimed at overcoming the unique challenges faced in deploying advanced connectivity services across homes and businesses in the region. Additionally, there will be discussions on leveraging digital connectivity to drive efficiency, foster community connections, and bridge the digital divide, thus promoting social and economic growth.

As a leader in IoT solutions, Wyld Networks is committed to driving innovation and excellence in connectivity. Founded in 2016 in Cambridge, United Kingdom, the company has consistently delivered state-of-the-art technology that facilitates seamless communication between sensors and satellite networks. With successful implementations across sectors such as agriculture, energy, utilities, logistics, and environmental projects, Wyld Networks empowers clients to harness the full potential of IoT data, leading to increased operational efficiency and informed decision-making.

"We are excited to showcase our IoT connectivity solutions at Connected North 2024 and engage with both existing partners and prospective customers," commented Eric Hewitson, Head of Communications for Wyld Networks UK.

Wyld Networks invites all interested parties to visit their booth during Connected North 2024 to explore the latest advancements in IoT connectivity. Attendees will have the opportunity to learn how Wyld Networks' innovative products, including Wyld Connect and Wyld Fusion, are shaping the future of digital connectivity in the Northern region.

Wyld Networks

@WyldNetworks

·

7h

Incredible milestone for IMAE - Inovação em Mecânica, Aeronáutica e Energia. The first wind turbine installed in a Telco Tower in Latin America. We are proud to play a part in providing #satelliteIoT connectivity for this amazing project.

#IoTSolutions #SustainableEnergy

Wyld Networks' sensor to satellite technology enters the Brazilian market for pollination monitoring through an agreement with GeoApis

Wyld Networks, together with Brazil-based GeoApis, has entered into an agreement to monitor bee colonies using Wyld's low-orbit satellite connection. Wyld Connect will support GeoApis to increase yields and improve sustainability for beekeepers, crop producers and growers to increase agricultural productivity.

Brazil is the third-largest agricultural producer and exporter in the world (Schneider et al., 2021), with about 60% of crops relying on pollinators in some way (Giannini et al., 2015).

In Brazil, the large agricultural areas and lack of rural coverage make it extremely difficult to monitor the health of pollinator populations.

Based in Brazil's Agtech Valley ecosystem in Piracicaba/SP, GeoApis works with over 300 beekeepers and over 4,000 bee colonies.

Specializing in reducing and preventing bee mortality, GeoApis focuses on the relationship between colony management and the use of pesticides and other agricultural ingredients. They protect bees and biodiversity by offering continuous eco-friendly solutions and projects to agricultural companies, agricultural producers and companies interested in sustainability.

With a coverage of over 500,000 hectares, GeoApis monitors more than 1 billion bees with customers in the sugar cane industry Wyld is meeting the challenges of connecting the Internet of Things in Brazil's agricultural sector via low-orbit satellites," said Alastair Williamson, CEO of Wyld Networks. "We are excited to partner with GeoApis on crucial projects that will have a significant impact on pollination and sustainability."

FundamentalVR CEO and Co-Founder Richard Vincent sat down with John Koetsier at Forbes, speaking on how surgeons are using Apple Vision Pro to improve training efficiency by decreasing skills acquisition time 40% to 100%.

Apple Vision Pro has allowed surgeons to upskill to a level where they can achieve “pre-human competence” all before stepping foot in an OR.

“Our vision is all about getting to something we call pre-human competence, which is don’t practice on me, practice on a simulated version of me and then come into the OR and perform on me.”

https://www.forbes.com/sites/johnkoetsier/2024/03/29/apple-vision-pro-could-reduce-surgeon-training-time-40-to-200/?sh=314bdbb369a2

https://fundamentalsurgery.com/medical-device-news-magazine-apple-vision-pro/